机构：[1]CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China[2]Department of Urology, Institute of Surgery Research, Daping Hospital, Army Medical University, Chongqing 400042, China[3]Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases, NHC Key Laboratory of Antibody Technique, Department of Microbes and Infection, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu 211166, China[4]State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China[5]State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai 200127, China[6]State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China[7]Department of Obstetrics, Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, 20 Renmin South Road, Chengdu 610041, China
This study was supported by grants from the National Key Research and
Development Program of China (2018YFA0902700), the National Natural Science
Foundation of China Distinguished Young Scholars Program (81825018),
the Strategic Priority Research Program of the Chinese Academy of Sciences
(XDB19000000 and XDA12000000), the Chinese Academy of Sciences
(QYZDB-SSW-SMC052), and the National Natural Science Foundation of
China Projects (81773121, 81802818, and 31970828). J.Q. is sponsored by
Program of Shanghai Academic/Technology Research Leader
(19XD1424300), and is a scholar in the National 1000 Young Talents Program
of China. N.L. is supported by the Initiative Postdocs Supporting Program by
MOHRSS and the National Postdoc Management Committee (bx201800247).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|1 区医学
小类|1 区肿瘤学1 区细胞生物学
最新[2023]版：
大类|1 区医学
小类|1 区细胞生物学1 区肿瘤学
第一作者：
第一作者机构：[1]CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China
共同第一作者：
通讯作者：
通讯机构：[1]CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China[2]Department of Urology, Institute of Surgery Research, Daping Hospital, Army Medical University, Chongqing 400042, China
推荐引用方式(GB/T 7714)：
Huairui Yuan,Ying Han,Xuege Wang,et al.SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.[J].Cancer cell.2020,38(3):350-365.e7.doi:10.1016/j.ccell.2020.05.022.
APA：
Huairui Yuan,Ying Han,Xuege Wang,Ni Li,Qiuli Liu...&Jun Qin.(2020).SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways..Cancer cell,38,(3)
MLA：
Huairui Yuan,et al."SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.".Cancer cell 38..3(2020):350-365.e7
医学